Global Type 1 Diabetes Market is Expected to Result in its Impressive Market Growth rate of More than 8.05% by 2020

Global Type 1 Diabetes Market 2016-2020 Size and Share Published in 2016-03-21 Available for US$ 2500 at Researchmoz.us

Description

About Type 1 Diabetes Drugs

Diabetes, often referred to as diabetes mellitus, results in high blood glucose levels. Depending on the cause of development, it can be divided into three types:

Type 1 diabetes (or insulin-dependent diabetes mellitus): The pancreas do not produce the required amount of insulin in the body, leading to high blood glucose levels.

Type 2 diabetes (non-insulin-dependent diabetes mellitus): In this condition, though the body produces the required amount of insulin, the cells do not respond to it. This results in a high glucose level in the body.

Gestational diabetes: This condition occurs in pregnant women without any history of diabetes.

Type 1 diabetes is an autoimmune disorder characterized by high blood glucose levels. In this condition, the immune system is activated against insulin-producing cells. This condition hampers the bodys ability to produce insulin and disrupts blood glucose homeostasis. Type 1 diabetes differs from a more prevalent form of diabetes mellitus, type 2 diabetes, wherein the insulin is produced inside the body. Type 1 diabetes accounts for only 5%-15% of the total diabetes cases. As the disease is more prevalent among children and adolescents aged 0-15 years, it was earlier known as juvenile diabetes. Type 1 diabetes management relies on providing symptomatic relief and improving the quality of life of people.

Technavios analysts forecast the global type 1 diabetes drugs market to grow at a CAGR of 8.05% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global type 1 diabetes drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded drugs and biosimilars used to treat and prevent type 1 diabetes.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Technavio’s report, Global Type 1 Diabetes Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Eli Lilly and Company

Novo Nordisk A/S

Sanofi SA

Get a Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=685165

Other prominent vendors

Adocia

Astellas Pharma

AstraZeneca

Baxalta

BHV Pharma

Biocon

Biodel

Boehringer Ingelheim

CureDM

Dance Biopharm

Diamyd Therapeutics AB

Diasome Pharmaceuticals

DiaVac

Exsulin

Gan & Lee Pharmaceuticals

Generex Biotechnology

GlaxoSmithKline

ILTOO Pharma

Intrexon

Islet Sciences

Kamada

Kotobuki Pharmaceutical

Lexicon Pharmaceuticals

Living Cell Technologie

MacroGenics

MannKind Pharmaceuticals

Merck

Merrion Pharmaceutical

Oramed Pharmaceuticals

Osiris Therapeutics

Perle Biosciences

Pfizer

REGiMMUNE

Strongbridge Biopharma

Toleranzia

Tolerio

Xeris Pharmaceuticals

XOMA

Market driver

Increase in prevalence of type 1 diabetes

For a full, detailed list, view our report

Market challenge

Poor storage conditions and distribution policies for insulin

For a full, detailed list, view our report

Market trend

Awareness programs and initiatives

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

Inquiry on this report: http://www.researchmoz.us/enquiry.php?type=E&repid=685165

Table of Content

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Key buying criteria

PART 05: Disease overview

Introduction

Risk factors

Diagnosis

Management

Epidemiology

Economic burden

PART 06: Insulin: An overview

Product portfolio

Global human insulin market

Browse All Healthcare Market Research Reports at: http://www.researchmoz.us/healthcare-market-reports-56.html

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/